Atomoxetine for the treatment of pediatric nocturnal enuresis
1Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. shatkinjp@upmc.edu
Insights
Four children with attention deficit hyperactivity disorder (ADHD) and nocturnal enuresis found their bedwetting resolved when treated with atomoxetine for ADHD. This medication offers a potential new avenue for treating comorbid ADHD and enuresis.
Area of Science:
- Pediatric medicine
- Neurology
- Psychiatry
Background:
- Current treatments for pediatric nocturnal enuresis include behavioral methods and medications like antidiuretic hormone analogs, tricyclic antidepressants, and anticholinergics.
- A significant portion of children do not fully respond to existing enuresis treatments, even with optimal management.
- Attention deficit hyperactivity disorder (ADHD) is a common comorbidity in children with nocturnal enuresis.
Observation:
- This report details four pediatric cases with comorbid ADHD and nocturnal enuresis.
- Each child received atomoxetine for their ADHD symptoms.
- A notable observation was the unexpected resolution of nocturnal enuresis in all four patients following atomoxetine treatment.
Findings:
- Atomoxetine, a medication primarily used for ADHD, demonstrated a serendipitous positive effect on nocturnal enuresis.
- The resolution of enuresis occurred in children who were treated for ADHD with atomoxetine.
- This suggests a potential link between ADHD treatment and enuresis improvement.
Implications:
- Atomoxetine may represent a novel therapeutic option for children experiencing both ADHD and nocturnal enuresis.
- Further research is warranted to explore the efficacy and mechanisms of atomoxetine in treating comorbid ADHD and enuresis.
- This finding could lead to improved management strategies for children with complex neurodevelopmental and urological conditions.
Abstract:
Current treatments for pediatric nocturnal enuresis rely upon the use of behavioral interventions, such as enuresis alarms, and pharmacological interventions, such as antidiuretic hormone analogs, tricyclic antidepressants, and anticholinergics. However, a considerable number of patients do not respond fully to any of these interventions, in spite of optimal behavioral management and medication dosing. This report describes 4 children with attention deficit hyperactivity disorder (ADHD) comorbid with nocturnal enuresis. Each child was treated with atomoxetine for ADHD and experienced serendipitous resolution of enuresis.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
The Micturition Reflex
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating urine...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...


